Accredited Animal Research BIOQUAL’s AAALAC accreditation combined with extensive in vivo and in vitro capabilities positions the company as a trusted, compliant partner for regulated studies in infectious disease and cancer. This can help win sponsorships from pharma, biotech, and government clients that demand high welfare standards and experienced veterinary oversight.

Integrated Capabilities The ability to conduct infectious disease investigations, cancer research, and both in vivo and in vitro studies from a single CRO creates opportunities to upsell integrated toxicology, pharmacology, and data management services across development stages.

Public Sector Growth BIOQUAL’s Maryland location near the DC ecosystem, coupled with its accreditation and specialized staff, supports pursuing government contracts and large scale biopharma programs through direct awards or subcontracts.

Revenue Stabilization Recent financial updates show revenue variability and losses; these dynamics underscore a sales angle focused on longer term contracts, multi year programs, and scalable study offerings to stabilize revenue while delivering consistent, high quality results.

Expertise Differentiation Highlight the depth of the team: research scientists, veterinarians, and animal care personnel, and the breadth of disease focus to attract universities, biotech startups, and established firms seeking rigorous, compliant research and reliable project execution.